$RGBP "The significance of these preclinical stud

$RGBP "The significance of these preclinical studies is that the data support our belief that controlling NR2F6 is key in treating autoimmune diseases such as arthritis by activating NR2F6. Additionally, the data suggest that by inhibiting NR2F6, these compounds can be used to treat cancer. In lay terms, if we turn the "light switch" on it causes NR2F6 to suppress the immune system thus potentially allowing treatment of rheumatoid arthritis and other autoimmune diseases. If we turn off the "light switch" we can cause the immune cells to be activated and kill cancer cells," stated David Koos, PhD, Chairman and CEO of Regen BioPharma Inc. "There are miles to go before we are finished but, these series of studies with Dr. Xiaojing Ma are very important. Regen believes we are on the verge of something extremely powerful in treating both autoimmunity and cancer."

http://tinyurl.com/ztyofyj

$RGBPP #biotech #houseofrespect #jobs #pharma #stocktip #job #science #ipo #goog #googl #AMGN #BIIB #CELG #GILD #REGN #VRTX #MYL

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!